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Abstract
We have established a pig resource population specifically designed to elucidate the genet-
ics involved in development of obesity and obesity related co-morbidities by crossing the
obesity prone Go¨ttingen Minipig breed with two lean production pig breeds. In this study we
have performed genome wide association (GWA) to identify loci with effect on blood lipid
levels. The most significantly associated single nucleotide polymorphisms (SNPs) were
used for linkage disequilibrium (LD) and haplotype analyses. Three separate haploblocks
which influence the ratio between high density lipoprotein cholesterol and total cholesterol
(HDL-C/CT), triglycerides (TG) and low density lipoprotein cholesterol (LDL-C) levels
respectively were identified on Sus Scrofa chromosome 3 (SSC3). Large additive genetic
effects were found for the HDL-C/CT and LDL-C haplotypes. Haplotypes segregating from
Go¨ttingen Minipigs were shown to impose a positive effect on blood lipid levels. Thus, the
genetic profile of the Go¨ttingen Minipig breed seems to support a phenotype comparable to
the metabolic healthy obese (MHO) phenotype in humans.
Introduction
Obesity is defined as excessive accumulation of fat in the body to the extent that it may have a
negative effect on health. According to the World Health Organization (WHO), in 2016 obe-
sity had more than doubled worldwide since 1980. Obesity can be socially stigmatizing, how-
ever, in itself it is not the primary health problem. Rather, it is the co-morbidities such as
cardiovascular disease (CVD) and type 2 diabetes (T2D) which pose the major health prob-
lems. Common to many of the co-morbidities is an unhealthy metabolic profile with insulin
resistance and dyslipidemia characterized by elevated triglycerides (TG) and low-density lipo-
protein cholesterol (LDL-C) levels and by decreased high-density lipoprotein cholesterol
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(HDL-C) concentrations [1]. Approximately 25% of obese humans do, however, not present
the metabolic complications and do not suffer from an increased susceptibility towards obesity
related diseases [2, 3]. These individuals are characterized as ’metabolically healthy obese’
(MHO) [4].
To understand why MHO individuals have a better prognosis than the metabolically
unhealthy individuals it is relevant to elucidate the genetic mechanisms underlying regulation
of blood lipids such as cholesterol and TG.
Cholesterol is a ubiquitous steroid and a vital component of cellular membranes in verte-
brates. But at the same time, subendothelial accumulation of cholesterol is the cause of athero-
sclerotic lesions leading to vascular diseases, heart attacks, aortic aneurysms and peripheral
vascular diseases [5] which, altogether, represent the most frequent causes of demise in the
industrialized world [6].
Cholesterol is transported in plasma in lipoprotein particles. These consist of a major struc-
tural apolipoprotein, peripheral apolipoproteins, structural lipids (phospholipids and choles-
terol) and a cargo of TG and steryl esters. Dietary lipids are absorbed via the small intestine
and packaged as TG into large particles known as chylomicrons (CM) which distribute lipids
throughout the body for direct use and storage. CM remnants return to the liver where the
remaining lipid cargo enters hepatic lipid pathways and a second class of lipoprotein particles
is produced; the very low density lipoproteins (VLDL). Like CM, VLDL distributes TG to the
periphery. As VLDL delivers TG they shrink and shed peripheral apolipoproteins, hence the
proportion of cholesterol increases and VLDL becomes low-density lipoproteins (LDL). Both
VLDL and LDL are characterized by the major structural apolipoprotein APOB. LDL can bind
to cells expressing the LDL-receptor (LDLR) and as such, LDL acts as an efficient cholesterol
delivery system into cells [5].
The reverse transport of cholesterol from the periphery to the liver is mediated by high-den-
sity lipoproteins (HDL) containing the major structural apolipoprotein APOA1. Nascent HDL
particles contain few lipids but collect free cholesterol and phospholipids from peripheral tis-
sues. Different mechanisms enrich the HDL particles with lipids, which ultimately are deliv-
ered to the liver via Scavenger Receptor B1 (SCARB1) for subsequent excretion with the bile
[5].
Heritability for LDL-C and HDL-C levels in humans are estimated to be around 70%.[7]
Large-scale genome wide association studies (GWAS) in humans have discovered over 150
common genetic variants associated with plasma lipids [8]. However, these loci only explain a
small fraction of the total variance in blood lipids [9] and the bulk of genetic factors for dyslipi-
demia are still unaccounted for.
A way to elucidate novel mechanisms involved in blood lipid regulation is to study animal mod-
els. Animal models provide the benefits of a strictly controlled diet and environment which is
impossible in large human studies. Consequently, random noise is greatly reduced and a corre-
sponding increase in power is presumed when animal models are used to study human conditions.
Also, the individual breeds are genetically more homogeneous than humans due to domestication
and artificial selection [e.g. ref. 10]. GWAS [11] and quantitative trait locus (QTL) mapping [12]
have been performed in mice to identify loci in the genome with effect on blood lipids. But more
frequently, spontaneous dyslipidemic and genetically engineered mouse models have been used to
study the effect of specific dyslipidemia associated genes first identified in human GWAS studies
[13]. However, market differences in metabolism and adipose tissue biology exists between rodents
and humans [e.g. ref. 14].
The pig is an animal model with a close similarity to humans in body size, physiology,
organ development and disease progression. It has been widely used as a model for cardiovas-
cular and metabolic diseases [15]. The presence of atherosclerotic lesions in aorta was
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described in pigs as early as 1954 [16]. The close similarity to vascular lesions in human athero-
sclerosis have later been confirmed [17, 18], and the pig has proved its value as a model for this
disease [19].
In the present study, a GWAS aimed at identifying loci with effect on blood lipid levels is
reported. The GWAS was performed in two pig crosses established by using Go¨ttingen Mini-
pig as the parental boar line in both crosses whereas Duroc and Yorkshire production pigs
were used as parental sow lines in the two crosses respectively. The Go¨ttingen Minipig is an
obesity prone pig breed [20] often used in studies of obesity, diabetes and metabolic syndrome
[21–24], whereas Duroc and Yorkshire pigs have been bred for leanness for decades. Haplo-
types were defined around the most significantly associated single nucleotide polymorphisms
(SNPs), and the effect of the haplotypes with the highest additive effects were studied further.
Materials and methods
Experimental animal model, sample collection and blood lipid analysis
Two populations were produced as F2 crosses using purebred Go¨ttingen Minipig (M), Duroc
(D) and Yorkshire (Y) as parental lines (Ellegaard Go¨ttingen Minipigs A/S, Dalmose, Den-
mark; DanBred International, Herlev, Denmark). The Minipig-Duroc (MD) crossbred F1 ani-
mals were founded by seven M boars and seven D sows and 28 F1 MD gilts and 16 F1 MD
boars were used to produce 285 F2 animals. Similarly, the Minipig-Yorkshire (MY) crossbred
F1 animals were founded by seven M boars and seven Y sows and 279 F2 animals were pro-
duced by 26 MY gilts and 13 MY boars (for further information see [25, 26]).
All pigs were raised under controlled environmental conditions and fed the same diet ad
libitum. The project was approved by the Danish Animal Experiments Inspectorate. Animal
care and maintenance were conducted according to the Danish “Act about Animal Hus-
bandry” and “Animal Protection Act” (Act 432, July 9, 2004; Act 1150, Sep. 12, 2015). All pigs
were housed at a regular pig farm, and slaughtered at a commercial slaughterhouse by stun-
ning and bleeding under veterinary supervision.
Blood samples for blood lipid analysis were drawn from the jugular vein at about two
month of age (63 ± 10 days, abbreviated Age1) and at slaughter (242 ± 48 days, abbreviated
Age2). Plasma lipid levels were assayed by standardized techniques using a Konelab 20 Clinical
Chemistry Analyzer (Thermo Scientific, Sweden) and commercial reagent kits from Roche
Diagnostics for Total Cholesterol (CT) and from ThermoElectron for TG and HDL-C levels
(direct method). LDL-C levels were calculated using the Friedewald formula. Observations >5
SD from the mean were considered outliers and excluded. Box-Cox transformation was used
to adjust for non-normality. After transformation, skewness and kurtosis were calculated for
each phenotypic distribution and Q-Q plots were made to evaluate normality.
Estimation of genetic parameters
Genetic parameters were estimated using Best Linear Unbiased Prediction (BLUP) based on
Average-Restricted Maximum Likelihood (AI-REML) using DMU version 6, release 5.2 [27].
Variance components were estimated using two different univariate models depending on
whether the phenotypes were measured at Age1 (Model 1) or Age2 (Model 2):
1Þ yi ¼ mþ SEXi þ CROSSi þ gðAGEiÞ þ xAi þ εi
2Þ yi ¼ mþ SEXi þ CROSSi þ g1ðAGEiÞ þ g2ðAGEiÞ
2
þ xAi þ εi
where y is the phenotype for animal i, μ is the population mean, SEX and CROSS are fixed
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effects for sex and cross (MD or MY) for animal i, AGE for animal i is a covariate with regres-
sion coefficient γ and A is the additive genetic effect for animal i with the regression coefficient
ξ. εi is the residual error. A and ε are assumed to be independent and normally distributed
with variances AσANIMAL2 and Iσε2, respectively. A is the additive genetic relationship matrix
based on pedigree information, σANIMAL2 the additive genetic variance, I an identity matrix of
appropriate size and σε2 the residual error variance.
A bivariate linear mixed model was fitted to estimate phenotypic and genetic correlations
between pairs of traits (Trait 1 and Trait 2):
y
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where y1 and y2 are vectors of the transformed phenotypic measurements of Trait 1 and Trait
2 respectively. X1 and X2 are design matrices connecting the measurements to b1 and b2 which
are vectors of the environmental fixed effects, while Z1 and Z2 are design matrices linking the
measurements to a1 and a2 which are vectors for the random genetic effects for each trait.
Finally, e1 and e2 are vectors of the random environmental effects. The effects fitted in the
bivariate linear mixed models are the same as the ones fitted in the univariate linear mixed
models. When fitting the bivariate model, the non-diagonals of the additive genetic variance
and covariance matrix G for animal effects and the variance and covariance matrix R for ran-
dom residual effects were included as follows:
As2A ¼ G ¼
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As2A2
2
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3
7
5 Is2e ¼ R ¼
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IcovE21
IcovE12
Is2E2
2
6
4
3
7
5
where covA12 = covA21 is the additive genetic covariance and covE12 = covE21 the random resid-
ual covariance between Trait 1 and 2. The phenotypic covariance covP12 = covP21 between
Trait 1 and 2 can be calculated as: covP12 = covA12 + covE12 [28].
Genotyping and Quality Control
Each animal was genotyped using the 60k porcine Illumina SNPchip. Sex chromosomes were
excluded from the single-marker analyses. The Sus Scrofa 10.2 pig genome assembly was used
to derive map positions for all SNPs. After genotyping, quality control (QC) was conducted
using GenABEL version 1.8–0 [29] excluding: animals and SNPs with more than 5% missing
genotypes; SNPs with a minor allele frequency (MAF) less than 5%; SNPs that significantly
deviated from Hardy-Weinberg equilibrium (HWE) at a significance threshold of p< 1E-05.
After QC, 549 pigs and 44,554 SNPs remained.
GWAS using single-marker test and estimation of SNP effects
GWAS was carried out for each phenotype using a single-marker test as implemented in Gen-
ABEL [30]. The analyses were performed in two steps: In step 1, the polygenic linear mixed
models were defined as Model 1 (for Age1) and Model 2 (for Age2) where Ai is the random
additive polygenic effect for animal i based on identity by state (IBS). Ai is assumed to be nor-
mally distributed with a (co)variance of GσANIMAL2 where G is the genomic relationship
matrix and σANIMAL2 the additive polygenic variance. Estimation of effects was performed by
means of maximum likelihood (ML) [31].
Genetics underlying the metabolically healthy obese phenotype
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Step 2 use estimated residuals from step 1 (contains part of the QTL variance) to estimate
SNP effects [30]:
ε^i ¼ mþ SNPm þ εm
where ε^i is the estimated residual error from step 1, μ is the mean, SNPm is assumed a fixed
effect with 3 genotype scores 0, 1 and 2 referring to the number of minor allele copies for the
m’th SNP and εm is the residual error. Each single SNP was modeled independently. The allele
substitution effect of the m’th SNP was calculated as the average phenotypic change when
replacing a major allele with the minor allele [32].
SimpleM [33–35] was used to correct for multiple testing by calculating the effective num-
ber of independent tests Meff = 12916. Missing genotypic values were replaced with the com-
mon allele genotype in the genotype matrix prior to the analysis. It resulted in a cut off value
of–log10(0.05/12916) = 5.41 corresponding to a nominal significance level (α) of 3.8710−6.
For each significant SNP, the phenotypic variance explained by the SNP was calculated as
[36]:
VSNP ¼ Vm ¼ 2qmð1   qmÞSN^Pm
2
where Vm is the phenotypic variance explained by the m’th SNP, qm is MAF for the m’th SNP
and SN^Pm is the estimated effect for the m’th SNP. The variance explained by the SNP is
assumed to be due to additive genetic variance. The proportion of additive genetic variance
explained by each SNP was calculated as VSNP / σA2. The additive genetic effect (α) for each
top-SNP was calculated using BLUP as implemented in DMU where the effect of having 0, 1
or 2 copies of a specific SNP was fitted in the models described above (Model 1 and Model 2).
Linkage disequilibrium and haplotype analysis
The method described by Gabriel et al.(2002) [37] as implemented in Haploview [38] was used
to define haploblocks around the top SNPs identified in the GWAS. Default parameters were
used except for “Fraction of strong LD in informative comparisons” which was set to>0.80
(default >0.95). Phased haplotypes for each haploblock for each individual were estimated
using the—hap-phase option in Plink [39]. The additive genetic effect of each haplotype was
estimated using BLUP by fitting the haplotype as a covariate in the models described above
(Model 1 and Model 2). Effect were fitted for one haplotype variant at a time by computing the
effect of having 0, 1 or 2 copies of that variant. Effects were only calculated for haplotype vari-
ants observed in the founder animals and not for variants found in less than 20 animals in the
F2 population.
To evaluate haplotype effects in individuals with high- and low-BMI respectively, all F2 ani-
mals were sorted according to BMI and the one-third with highest BMI (high BMI) and lowest
(low BMI) respectively were selected. Each of the groups were subdivided according to haplo-
types in the HDL-C/CT and the LDL-C QTL regions and mean and standard deviation for
BMI_Age2, CT_Age2, TG_Age2, HDL-C/CT_Age1, HDL-C_Age2, HDL-C/CT_Age2,
LDL-C_Age2 and LDL-C/HDL-C at Age2 were calculated separately using Students-t test for
animals which were homozygous for either the GM or the Yorkshire/Duroc haplotypes in the
HDL-C/CT and LDL-C QTL regions.
Results
A moderate genetic correlation was found between Age1 and Age2 both in regard to LDL-C
and HDL-C/CT, whereas, for TG there was no correlation between measurements at the two
ages (see Table 1).
Genetics underlying the metabolically healthy obese phenotype
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The GWA study resulted in the identification of several QTL regions below the nominal
significance level on sus scrofa chromosome 3 (SSC3) (see Table 2). A single SNP on SSC3 at
124.7 Mb is associated with TG_Age2, whereas, there is no indication for an association with
TG_Age1 at this position (data not shown). Conversely, the same loci on SSC3 are associated
with LDL-C at Age 1 and Age 2 and the same is true for HDL-C/CT. The most significant asso-
ciations for LDL-C are found around 125.6 Mb and the most significant SNPs for HDL-C/CT
are found at 122.8 Mb.
LD analysis (Fig 1) revealed that the two top SNPs for HDL-C/CT_Age1 and HDL-C/
CT_Age2 are located close together and belong to the same LD-block defined by six SNPs
from 122.7–122.9 Mb (designated ’1’ in Fig 1). The top SNP’s for TG_Age2 and LDL-C_Age1
and Age2 show minimal LD to surrounding SNPs and are not included in any LD blocks
when default parameters in Haploview are used (results not shown). Relaxing the parameters
for block definition, as described above, includes the top SNP for LDL-C_Age2 into an LD
block defined by 10 SNPs spanning a region from 125.6–125.9 Mb (designated ’3’ Fig 1), but
the top SNP for LDL-C_Age1 is still outside the LD block. In the same way the relaxed parame-
ters include the top SNP for TG_Age2 into a four SNP haploblock from124.67–124.75 Mb
(designated ’2’ in Fig 1) clearly separated from the HDL-C/CT and the LDL-C loci. The SNPs
located in the haploblocks associated with the lipid levels are listed in SI 1.
The additive genetic effect of haplotypes present in more than 20 animals is shown in
Table 3. The largest additive effects appear for the HDL-C/CT and LDL-C haplotypes for
which there is also a clear breed specific segregation. For the HDL-C/CT associated haplotypes
one specific haplotype, AAAGGG, impose a higher HDL-C/CT level. Twelve out of fourteen
Go¨ttingen Minipig founders are homozygous for this haplotype and the remaining two has
one copy of AAAGGG. The haplotype GGGAAA, for which all Yorkshire founders are homo-
zygous, has an equivalent negative effect, that is, animals with this haplotype have lower
HDL-C/CT levels. The same trend is true for the haplotypes segregating from the Duroc
Table 1. Genetic (rA) and phenotypic (rP) correlation between phenotypes measured at different age.
Phenotypes Correlation coefficients
Trait 1 Trait 2 rA (SE) rP
TG_Age1 TG_Age2 0.01 (0.28) -0.07
LDL-C_Age1 LDL-C_Age2 0.41 (0.19) 0.31
HDL-C/CT_Age1 HDL-C/CT_Age2 0.21 (0.24) 0.29
Age1: 63 ± 10 days, Age1; Age2: 242 ± 48 days
https://doi.org/10.1371/journal.pone.0178828.t001
Table 2. QTL regions and SNP effects.
Phenotypes Most significant SNP on SSC3 SNP effect
SNP name Position P-value MA MAF MAF (GM) MAF (DD) MAF (YY) VSNP/σA2 α (SE)
TG_Age2 ALGA0021201 124739382 3.35E-06 A 0.36 0.00 0.70 0.83 0.34 -0.02 (0.00)
LDL-C_Age1 ASGA0094490 125568713 1.34E-08 A 0.38 0.00 0.60 0.83 0.17 0.05 (0.01)
LDL-C_Age2 ASGA0106214 125592465 2.07E-07 A 0.20 0.41 0.00 0.00 0.13 -0.05 (0.01)
HDL-C/CT_Age1 ALGA0021148 122811986 2.12E-09 G 0.39 0.00 0.60 1.00 0.20 -0.04 (0.00)
HDL-C/CT_Age2 MARC0019977 122854537 3.91E-07 A 0.42 0.00 0.70 1.00 0.26 -0.03 (0.01)
MA: Minor allele; MAF: Minor allele frequency; MAF (GM), (DD), (YY): Minor allele frequency in the parental generation of Go¨ttingen minipigs, Duroc and
Yorkshire respectively; VSNP/σA2: Proportion of additive genetic variance explained by each SNP; α (SE): additive genetic effect for each top-SNP
(standard error)
https://doi.org/10.1371/journal.pone.0178828.t002
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breed, and among the Duroc haplotypes, AGAAGA, has an even stronger negative effect com-
pared to the Yorkshire haplotype on the HDL-C/CT level. The effect of the individual haplo-
types is similar at Age 1 and Age 2 (data not shown).
For the LDL-C associated LD block, the haplotype AGGAGCCAAA originating from
the Go¨ttingen Minipig founders, decrease the LDL-C level. The Yorkshire founder specific
Fig 1. LD in a 2.8 Mb region (122.4–126.1 Mb) on Sus Scrofa chromosome 3. Frames mark top SNPs for HDL-C/CT_Age1, HDL-C/
CT_Age2, TG_Age2, LDL-C_Age1 and LDL-C_Age2, in this order from left to right. Triangles indicate haploblock structure in the QTL
region. Block 1: QTL for HDL-C/CT; Block 2: QTL for TG; Block 3: QTL for LDL-C.
https://doi.org/10.1371/journal.pone.0178828.g001
Table 3. Haplotype effects—SSC3.
Phenotype Haplotype Haploblock Additive effect SE Origine*
HDL-C/CT AAAGAA 1 -0.02 0.01 D
AAAGGA 0.01 0.01 GM
AAAGGG 0.04 0.00 GM
AGAAGA -0.07 0.01 D
AGGAAA -0.02 0.02 D
GAAAGA -0.02 0.02 D
GGGAAA -0.04 0.01 Y
TG Age2 AAAA 2 -0.02 0.00 Y, D
GACA 0.01 0.00 GM, Y
GGAA -0.02 0.01 D
GGCG 0.01 0.01 D
LDL-C AGGAGCCAAA 3 -0.04 0.01 GM
GAAAGAAACG 0.01 0.01 D
GGAAGAAACG -0.02 0.02 Y
GGAAGAAGAG 0.03 0.02 Y
GGAAGAAGCG 0.02 0.01 Y
GGGAGCCAAA 0.01 0.01 GM
GGGAGCCGAG 0.00 0.02 D
GGGGAACAAG 0.02 0.01 D
Effect of haplotypes present in more than 20 animals in the population in the three QTL haploblocks
*: GM = Go¨ttingen Minipig; Y = Yorkshire; D = Duroc
https://doi.org/10.1371/journal.pone.0178828.t003
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haplotypes, GGAAGAAGAG and GGAAGAAGCG, increase LDL-C level; however, there is
also one Yorkshire haplotype, GGAAGAAACG, which decreases LDL-C level. Two of the
Duroc haplotypes increase the LDL-C level slightly. The effect of each haplotype is the same at
Age 1 and Age 2 (data not shown) even though the blocks are only loosely in LD according to
the LD analysis.
To further evaluate the phenotypic consequences of the haplotypes segregating from Go¨t-
tingen Minipig and Yorkshire/Duroc respectively we compared lipid and TG levels in animals
homozygous for either Go¨ttingen Minipig haplotypes or the Duroc/Yorkshire haplotypes. The
comparison was performed in the one-third of the F2 animals with the highest and one-third
with lowest BMI, respectively. The mean BMI in the combined F2 population (564 animals) is
127±20 while in the selected high BMI group (136 animals) the mean BMI is 154±13, and in
the selected low BMI group (132 animals) the mean BMI is 111±9. As seen in Table 4, within
the low BMI group of animals there are no differences in TG and lipid values between the
genetically diverse animals. However, when comparing animals homozygous for Go¨ttingen
Minipig haplotypes with animals homozygous for Yorksire/Duroc haplotypes within the high
BMI group of animals both TG and lipid values (except HDL-C) are significantly higher in ani-
mals with the Yorkshire/Duroc haplotypes.
Discussion
In agreement with previously performed GWA studies in pigs [26, 40, 41], we have identified
a QTL region influencing lipoprotein traits on SSC3. The homologous region on human
chromosome 2 has also been implicated in the regulation of blood lipids in human GWA
studies [42]. Our study shows that three separate haplopblocks influence HDL-C/CT -, TG -,
and LDL-C levels respectively (see Fig 1). The HDL-C/CT and HDL-C QTL loci flank the
TG_Age2 locus and thus, this 2.8 Mb region on SSC3 seems to encompass several loci with a
regulatory effect on different plasma lipids. This is underpinned by the observation that the
SSC3 locus affects HDL-C and LDL-C levels independent of age but for TG-levels there is only
an association to TG_Age2 and no evidence suggesting an association to TG_Age1. This indi-
cates that different genes or regulatory mechanisms in the region are responsible for effects on
cholesterol and triglyceride levels, respectively. This is also in agreement with the observed
correlations between phenotypes at different ages (Table 1) and the lack of a correlation be-
tween TG at Age1 and Age2.
Table 4. Effects of HDL-C/CT and LDL-C haplotypes with high additive effect in high- and low-BMI individuals.
BMI_Age2 CT_Age2 TG_Age2 HDL-C/CT
Age1
HDL-C_Age2 HDL-C/CT
Age2
LDL-C_Age2 LDL-C/HDL-C
Age2
n
High BMI
GM/GM 157.56 (14.00) 2.28 (0.49) 0.45 (0.18) 0.54 (0.07) 1.40 (0.31) 0.62 (0.07) 0.68 (0.27) 0.49 (0.17) 28
D/D or Y/Y 149.75 (16.05) 2.55 (0.55) 0.71 (0.35) 0.47 (0.06) 1.30 (0.35) 0.51 (0.10) 0.93 (0.33) 0.79 (0.46) 22
t-test 0.037468 0.034815 0.000744 0.00044 0.164139 7.38E-05 0.002637 0.001605
Low BMI
GM/GM 112.62 (9.38) 2.26 (0.84) 0.44 (0.23) 0.51 (0.10) 1.25 (0.54) 0.56 (0.10) 0.80 (0.35) 0.68 (0.31) 32
D/D or Y/Y 112.81 (6.00) 2.28 (0.67) 0.46 (0.17) 0.45 (0.07) 1.28 (0.44) 0.57 (0.11) 0.79 (0.39) 0.67 (0.41) 22
t-test 0.465747 0.464812 0.420131 0.017532 0.420304 0.379878 0.44152 0.462115
Mean and standard deviation (in parentheses) for eight phenotypes in high and low BMI animals homozygous for the Go¨ttingen Minipig haplotypes (GM/
GM) or Yorkshire (Y/Y) or Duroc (D/D) haplotypes in haploblock 1 (HDL-C/CT) and 3 (LDL-C).
https://doi.org/10.1371/journal.pone.0178828.t004
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There are no annotated known genes in the HDL-C/CT and TG associated SSC3 haplo-
blocks in the Sscrofa 10.2 assembly but the gene encoding ras homolog family member B
(RHOB) is located in the LDL-C associated haploblock. RHOB is a member of the RHO GTP-
binding protein family which regulates expression of CD36 [43]. CD36 is a scavenger protein
with high affinity for plasma lipoproteins including LDL and a high expression in tissues such
as skeletal muscle, heart, mammary, epithelium and adipose tissue, with a very active fatty acid
metabolism [44]. The gene encoding apolipoprotein B (APOB) is located at 125.23–125.35 Mb.
It is an obvious candidate gene for lipid related traits but in the present study it is not included
in associated LD-blocks even though it was covered by four SNPs with a MAF above the exclu-
sion threshold. The gene encoding lipid droplet associated hydrolase (LDAH) is located at
125.42–125.53 Mb which is also outside the identified LD-blocks. Further studies including
sequencing and genotyping of additional markers are warranted to ascertain LD structure and
to identify genetic variation. It is very likely that the observed differences in blood lipids are
caused by variation in regulatory components within the identified QTL regions in particular
since a high number of different genes involved in regulation of lipoproteins are located within
this region of the genome.
Investigation of the additive genetic effect of the most common haplotypes segregating
within the F2 population indicates that the haplotypes originating from the Go¨ttingen Minipig
breed provide a healthier lipid profile compared to the haplotypes segregating from the York-
shire and Duroc breeds. I.e., Go¨ttingen Minipig haplotypes in haploblock 1 appears to increase
HDL-C/CT compared to the Yorkshire and Duroc haplotypes, which have the opposite effect.
Conversely, in haploblock 3 the Go¨ttingen Minipig haplotype lowers the level of LDL-C and
the Yorkshire and Duroc haplotype increases LDL-C level with the exception of the GGAA-
GAAACG haplotype segregating from the Yorkshire breed. This effect is confirmed by com-
paring animals homozygous for the Go¨ttingen Minipig and Duroc/Yorkshire haplotypes
respectively within groups of animals with high and low BMI respectively. Within the high
BMI group animals with Go¨ttingen Minipig haplotypes have a significantly lower TG level,
lower levels of LDL-C, and LDL-C/HDL-C ratio and higher ratio of HDL-C to CT (Table 4).
Within the low BMI group there is no difference in the phenotypes between the two genetic
variants. Thus, overall Go¨ttingen Minipig seems to have a genotype that supports a more
healthy blood lipid profile in spite of the fact that they are prone to obesity. Or conversely, pigs
without the Go¨ttingen Minipig haplotypes develop a more unhealthy, dyslipidemic profile
together with obesity, compared to pigs with Go¨ttingen Minipig haplotypes which uphold a
healthy lipid profile despite development of severe obesity.
The Gottingen Minipig breed was developed in the 1960’s using Minnesota Minipigs, Viet-
namese Potbelly Pigs, and German Landrace as founders (Simianer and Ko¨hn, 2010). A likely
explanation for the MHO profile in Go¨ttingen Minipigs is that the obesity prone minipig foun-
ders have been adapted to overcome obesity by natural selection. Thus, unexpectedly, the
results presented here indicate that the Go¨ttingen Minipig breed is not well suited for studies
of the obesity related co-morbidities but may be a valuable model to advance understanding of
the MHO phenotype in humans.
The MHO profile identified in our F2 population is comparable to the MHO profile in
humans which appear to be protected against obesity related metabolic complications. How-
ever, although MHO is an important, emerging phenotype in humans no universally accepted
definition has been established for this phenotype yet [45]. It is also debated to what extend
MHO individuals will remain healthy [46, 47]. On the other hand, studying MHO subjects
may lead to better intervention strategies for metabolically unhealthy obese people, and elu-
cidate if they by lifestyle changes or by the use of medicine can switch to a better metabolic
profile.
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In conclusion, we have substantiated that different genetic loci have an effect on TG early
and late in life. We have also substantiated that the genomic region close to genes implicated
in lipoprotein metabolism (RHOB, APOB, LDAH) comprise regulatory elements of impor-
tance to the regulation of lipid metabolism. Interestingly, the largest additive genetic effects of
the haplotypes identified in this study show that haplotypes segregating from the obesity prone
Go¨ttingen Minipig breed is able to uphold a healthy lipid profile despite development of obe-
sity. Thus, the genetic profile of the Go¨ttinging Minipig breed seems to support a phenotype
comparable to the MHO phenotype in humans promoting this pig breed as a model for further
studies of this particular phenotype. Our future studies will be directed at identification the
genetic variation in the regulatory components involved in lipid metabolism and further ge-
netic characterization of the healthy metabolic phenotype.
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